Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 19651-19700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02399995
Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over Time
N/AActive, not recruiting
219 participants
Started: Mar 31, 2015 · Completed: Mar 31, 2026
1 condition1 sponsor7 locations
NCT04242524
The Impact of Bariatric Surgery on Adipocyte Metabolism
NAActive, not recruiting
82 participants
Started: Mar 26, 2015 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02296684
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
PHASE2Active, not recruiting
67 participants
Started: Mar 25, 2015 · Completed: Dec 31, 2025
6 conditions2 sponsors3 locations
NCT02386709
Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer
NAActive, not recruiting
275 participants
Started: Mar 25, 2015 · Completed: Mar 25, 2028
1 condition1 sponsor1 location
NCT02352883
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
NAActive, not recruiting
368 participants
Started: Mar 25, 2015 · Completed: Nov 30, 2027
1 condition3 sponsors76 locations
NCT02166463
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
PHASE3Active, not recruiting
600 participants
Started: Mar 19, 2015 · Completed: Oct 3, 2025
6 conditions1 sponsor199 locations
NCT02386917
Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers
NAActive, not recruiting
100 participants
Started: Mar 18, 2015 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT02387905
Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases
PHASE2Active, not recruiting
87 participants
Started: Mar 9, 2015 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT02381886
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
PHASE1Active, not recruiting
166 participants
Started: Mar 6, 2015 · Completed: Feb 3, 2026
1 condition1 sponsor16 locations
NCT02386800
CINC424A2X01B Rollover Protocol
PHASE4Active, not recruiting
279 participants
Started: Mar 5, 2015 · Completed: Sep 16, 2027
5 conditions1 sponsor98 locations
NCT02389517
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
PHASE2Active, not recruiting
42 participants
Started: Mar 2, 2015 · Completed: Mar 31, 2027
2 conditions3 sponsors1 location
NCT02213926
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
PHASE2Active, not recruiting
124 participants
Started: Mar 2, 2015 · Completed: Sep 6, 2026
1 condition1 sponsor58 locations
NCT02287311
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
PHASE1Active, not recruiting
38 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2029
6 conditions3 sponsors2 locations
NCT02203643
Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
PHASE2Active, not recruiting
477 participants
Started: Feb 28, 2015 · Completed: Mar 26, 2026
1 condition1 sponsor1 location
NCT02603679
Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases
PHASE2Active, not recruiting
181 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2031
2 conditions1 sponsor3 locations
NCT02318732
Evaluation of California's Armed and Prohibited Persons System
NAActive, not recruiting
20,000 participants
Started: Feb 28, 2015 · Completed: Jun 21, 2025
1 condition4 sponsors1 location
NCT02339064
Infusion of Apomorphine: Long-term Safety Study
PHASE3Active, not recruiting
99 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor18 locations
NCT02065362
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
PHASE1Active, not recruiting
14 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2033
1 condition4 sponsors1 location
NCT02375841
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
N/AActive, not recruiting
309 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions2 sponsors8 locations
NCT02294435
Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms
NAActive, not recruiting
250 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT02371135
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes
N/AActive, not recruiting
77 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
2 conditions3 sponsors1 location
NCT02369003
Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS
PHASE1Active, not recruiting
70 participants
Started: Feb 28, 2015 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT02387736
DBT for Chronically Self-harming Individuals With BPD: Evaluating the Clinical & Cost Effectiveness of a 6 mo. Treatment
NAActive, not recruiting
240 participants
Started: Feb 28, 2015 · Completed: Mar 31, 2025
1 condition3 sponsors2 locations
NCT02340676
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
PHASE2Active, not recruiting
25 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02407808
Cannabinoids, Learning, and Memory
PHASE1Active, not recruiting
80 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT02370797
Node Negative, Invasive Breast Cancer Single Fraction IOERT
NAActive, not recruiting
100 participants
Started: Feb 28, 2015 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT02678182
Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial
PHASE2Active, not recruiting
494 participants
Started: Feb 28, 2015 · Completed: Jun 30, 2027
3 conditions5 sponsors1 location
NCT02297672
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
NAActive, not recruiting
75 participants
Started: Feb 28, 2015 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT02346747
A Trial of Vigil for Participants With Ovarian Cancer
PHASE2Active, not recruiting
92 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
2 conditions1 sponsor26 locations
NCT02365090
Binocular iPad Sub-Study
NAActive, not recruiting
96 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03531658
Singapore PREconception Study of Long-Term Maternal and Child Outcomes
N/AActive, not recruiting
1,054 participants
Started: Feb 27, 2015 · Completed: Dec 31, 2029
7 conditions3 sponsors1 location
NCT01209871
Vaccine Therapy in Treating Patients With Lymphoplasmacytic Lymphoma
PHASE1Active, not recruiting
9 participants
Started: Feb 26, 2015 · Completed: Feb 20, 2026
1 condition2 sponsors1 location
NCT02122185
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2Active, not recruiting
110 participants
Started: Feb 25, 2015 · Completed: Feb 25, 2027
28 conditions1 sponsor10 locations
NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer
PHASE2Active, not recruiting
62 participants
Started: Feb 25, 2015 · Completed: Jul 31, 2041
9 conditions3 sponsors1 location
NCT01896479
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
PHASE4Active, not recruiting
247 participants
Started: Feb 25, 2015 · Completed: Jan 31, 2035
1 condition1 sponsor49 locations
NCT02273375
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
PHASE3Active, not recruiting
1,415 participants
Started: Feb 24, 2015 · Completed: Jan 31, 2026
1 condition11 sponsors271 locations
NCT02362503
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
PHASE3Active, not recruiting
371 participants
Started: Feb 23, 2015 · Completed: Sep 30, 2026
1 condition1 sponsor139 locations
NCT02362035
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
PHASE1/PHASE2Active, not recruiting
161 participants
Started: Feb 20, 2015 · Completed: Apr 1, 2026
13 conditions2 sponsors19 locations
NCT02210078
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection
PHASE2Active, not recruiting
49 participants
Started: Feb 19, 2015 · Completed: Aug 31, 2027
3 conditions2 sponsors1 location
NCT02193282
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
PHASE3Active, not recruiting
450 participants
Started: Feb 11, 2015 · Completed: Oct 10, 2026
6 conditions1 sponsor1411 locations
NCT02718001
Edwards EVOQUE Eos MISCEND Study
NAActive, not recruiting
123 participants
Started: Feb 6, 2015 · Completed: Apr 30, 2033
1 condition1 sponsor19 locations
NCT02307058
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy
NAActive, not recruiting
164 participants
Started: Feb 5, 2015 · Completed: Jul 31, 2031
1 condition1 sponsor1 location
NCT02270814
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
PHASE2Active, not recruiting
74 participants
Started: Feb 2, 2015 · Completed: Dec 31, 2025
3 conditions2 sponsors5 locations
NCT02320435
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
PHASE3Active, not recruiting
154 participants
Started: Feb 2, 2015 · Completed: Dec 31, 2026
1 condition1 sponsor61 locations
NCT02382822
Copenhagen Comorbidity in HIV Infection Study
N/AActive, not recruiting
1,099 participants
Started: Feb 1, 2015 · Completed: Dec 31, 2035
4 conditions1 sponsor2 locations
NCT04738968
Cochlear Implantation for Young Single-sided Deaf Children
NAActive, not recruiting
70 participants
Started: Jan 31, 2015 · Completed: Dec 31, 2026
1 condition4 sponsors4 locations
NCT02344498
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa
N/AActive, not recruiting
7,350 participants
Started: Jan 31, 2015 · Completed: Dec 31, 2026
1 condition7 sponsors1 location
NCT02128555
Total Ankle Replacement Versus Arthrodesis Trial
NAActive, not recruiting
303 participants
Started: Jan 31, 2015 · Completed: Feb 28, 2029
1 condition2 sponsors17 locations
NCT02610023
Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults
N/AActive, not recruiting
100 participants
Started: Jan 31, 2015 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT02328872
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia
NAActive, not recruiting
76,181 participants
Started: Jan 31, 2015 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location